Decompression Sickness
14
1
2
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (14)
NASA Prebreathe Study
Rhu-pGSN to Mitigate Proinflammatory Responses to Decompression in Healthy SCUBA Divers
Epidemiological Assessment of Technical Diving Accidents in Mainland France and Factors Predictive of Severity (TEKCare)
Prediction & Mechanisms of Recovery Following IEDS
Markers of Central Nervous System Injury in Decompression Sickness
Impact of Hyperoxia and Involvement of the Immune System in Diving Accident
Reduction of Venous Emboli Load After Breathing Normobaric Oxygen Compared to Air
Decompression Tables for Diving at Altitude
Decompression Sickness in Divers With or Without Patent Foramen Ovale
Hyperbaric Oxygen Therapy Registry
Decreases in Diffusing Lung Capacity for Carbon Monoxide (DLCO) in Occupational Divers and Their Impact on Decompression Sickness Risks
Microparticles in Scuba Divers With Decompression Sickness
Exercise and Repetitive Diving
High Intensity Cycling Before SCUBA Diving Reduces Post-decompression Microparticle Production and Neutrophil Activation